Wound Care Biologics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Wound Care Biologics Market is Segmented by Product (Biological Skin Substitutes and Topical Agents), Wound Type, End User, and Geography.

Market Snapshot

Wound Care Biologics Market Overview
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: >8 %
Wound Care Biologics Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Wound care biologics is gaining popularity for the treatment of wounds and burn injuries. Factors, such as growing burden of burn injuries, increasing burden of diabetic foot ulcers, and government initiatives regarding wound care treatment are driving the growth of the wound care biologics market.

  • The incidence of diabetes among all ages is increasing, mainly due to obesity, unhealthy diet, and physical inactivity. According to the International Diabetes Federation, in 2019, there were around 4.2 million deaths globally due to diabetes.
  • The incidence of chronic wounds, especially foot ulcers is increasing among the diabetic population, resulting in the increased usage of wound care biologics products. Therefore, the growing focus toward the development of better treatment options, along with the huge burden of diseases, is expected to drive the wound care biologics market. However, the high treatment cost is expected to restrain the growth of the global market in the forecast period.

Scope of the Report

As per the scope of the report, wound care biologics refer to products that are used for controlling and healing infections. Wound healing is a complex process involving inflammation, accumulation of tissue, deposition of collagen, and formation of epithelial cell layers.

By Product
Biological Skin Substitutes
Topical Agents
By Wound Type
Diabetic Foot Ulcers
Venous Ulcers
Pressure Ulcers
Other Ulcers
Surgical and Traumatic Wounds
End User
Ambulatory Surgical Centers
Other End Users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Biological Skin Substitutes Segment is Expected to Witness Better Growth Over the Forecast Period

Based on products, the market is segmented into biological skin substitutes and topical agents. The biological skin substitutes segment is expected to witness better growth due to their wide usage in the treatment of chronic wounds. These skin substitutes have an intact extracellular matrix for structural support. Biological skin substitutes are majorly recommended for burn injuries and treatment of chronic wounds, such as diabetic foot ulcers and venous leg ulcers. According to the International Diabetes Federation, in 2019, almost 463 million people (20-79 years) had diabetes, and by 2045, this is expected to rise to 700 million. Chronic wounds lead to complications, such as infection, ulceration, and insufficient blood supply. Hence, the increasing burden of diabetes and the growing adoption of these products are the major factors propelling the growth of the wound care biologics market.

Wound Care Biologics Market Key Trends

North America Dominates the Wound Care Biologics Market

North America is expected to dominate the wound care biologics market during the forecast years. This is mainly attributed to the growing diabetic population and the rising number of burn injury cases in the region. According to the American Burn Association, approximately 450,000 patients receive hospital and emergency room treatment for burns each year. Burn injury is one of the leading causes of unintentional death in the United States, which leads to increased adoption of wound care biologics by the hospitals or clinics. Hence, increased awareness, rapid adoption of new technologies, and increasing chronic wound cases are expected to positively impact market growth in this region.

Wound Care Biologics Market Growth by Region

Competitive Landscape

The wound care biologics market is competitive and many of the global players are in the market. For instance, ACell Inc., Integra LifeSciences Corporation, Kerecis, Marine Polymer Technologies Inc., MiMedx Inc., Misonix, Inc., Mölnlycke Health Care, Smith & Nephew PLC, and Wright Medical Group NV are providing these products across the world.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Burn Injuries and Road Accidents

      2. 4.2.2 Government Initiatives Regarding Wound Care Treatment

    3. 4.3 Market Restraints

      1. 4.3.1 High Treatment Cost

      2. 4.3.2 Stringent Regulatory Guidelines and Challenges Faced by the Manufacturers

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Biological Skin Substitutes

      2. 5.1.2 Topical Agents

    2. 5.2 By Wound Type

      1. 5.2.1 Ulcers

        1. Diabetic Foot Ulcers

        2. Venous Ulcers

        3. Pressure Ulcers

        4. Other Ulcers

      2. 5.2.2 Surgical and Traumatic Wounds

      3. 5.2.3 Burns

    3. 5.3 End User

      1. 5.3.1 Hospitals/Clinics

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 ACell Inc.

      2. 6.1.2 Integra LifeSciences Corporation

      3. 6.1.3 Kerecis

      4. 6.1.4 Marine Polymer Technologies Inc.

      5. 6.1.5 MiMedx Inc.

      6. 6.1.6 MISONIX Inc.

      7. 6.1.7 Molnlycke Health Care

      8. 6.1.8 Smith & Nephew PLC

      9. 6.1.9 Wright Medical Group NV

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Wound Care Biologics Market market is studied from 2018 - 2026.

The Wound Care Biologics Market is growing at a CAGR of >8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Integra LifeSciences Corporation, MISONIX, Inc., Mölnlycke Health Care, Smith & Nephew plc, Wright Medical Group N.V.. are the major companies operating in Wound Care Biologics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!